» Articles » PMID: 35758712

In Vitro Apical-Out Enteroid Model of Necrotizing Enterocolitis

Overview
Journal J Vis Exp
Date 2022 Jun 27
PMID 35758712
Authors
Affiliations
Soon will be listed here.
Abstract

Necrotizing enterocolitis (NEC) is a devastating disease affecting preterm infants, characterized by intestinal inflammation and necrosis. Enteroids have recently emerged as a promising system to model gastrointestinal pathologies. However, currently utilized methods for enteroid manipulation either lack access to the apical surface of the epithelium (three-dimensional [3D]) or are time-consuming and resource-intensive (two-dimensional [2D] monolayers). These methods often require additional steps, such as microinjection, for the model to become physiologically translatable. Here, we describe a physiologically relevant and inexpensive protocol for studying NEC in vitro by reversing enteroid polarity, resulting in the apical surface facing outward (apical-out). An immunofluorescent staining protocol to examine enteroid barrier integrity and junctional protein expression following exposure to tumor necrosis factor-alpha (TNF-α) or lipopolysaccharide (LPS) under normoxic or hypoxic conditions is also provided. The viability of 3D apical-out enteroids exposed to normoxic or hypoxic LPS or TNF-α for 24 h is also evaluated. Enteroids exposed to either LPS or TNF-α, in combination with hypoxia, exhibited disruption of epithelial architecture, a loss of adherens junction protein expression, and a reduction in cell viability. This protocol describes a new apical-out NEC-in-a-dish model which presents a physiologically relevant and cost-effective platform to identify potential epithelial targets for NEC therapies and study the preterm intestinal response to therapeutics.

Citing Articles

Immunological aspects of necrotizing enterocolitis models: a review.

Blum L, Vincent D, Boettcher M, Knopf J Front Immunol. 2024; 15:1434281.

PMID: 39104529 PMC: 11298363. DOI: 10.3389/fimmu.2024.1434281.


Neonatal enteroids absorb extracellular vesicles from human milk-fed infant digestive fluid.

Yung C, Zhang Y, Kuhn M, Armstrong R, Olyaei A, Aloia M J Extracell Vesicles. 2024; 13(4):e12422.

PMID: 38602306 PMC: 11007820. DOI: 10.1002/jev2.12422.


The role of human milk nutrients in preventing necrotizing enterocolitis.

Sami A, Frazer L, Miller C, Singh D, Clodfelter L, Orgel K Front Pediatr. 2023; 11:1188050.

PMID: 37334221 PMC: 10272619. DOI: 10.3389/fped.2023.1188050.

References
1.
Khailova L, Dvorak K, Arganbright K, Halpern M, Kinouchi T, Yajima M . Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2010; 297(5):G940-9. PMC: 2777452. DOI: 10.1152/ajpgi.00141.2009. View

2.
Nolan L, Gong Q, Hofmeister H, Good M . A protocol for the induction of experimental necrotizing enterocolitis in neonatal mice. STAR Protoc. 2021; 2(4):100951. PMC: 8593655. DOI: 10.1016/j.xpro.2021.100951. View

3.
Li B, Lee C, Cadete M, Miyake H, Lee D, Pierro A . Neonatal intestinal organoids as an ex vivo approach to study early intestinal epithelial disorders. Pediatr Surg Int. 2018; 35(1):3-7. DOI: 10.1007/s00383-018-4369-3. View

4.
Neu J, Walker W . Necrotizing enterocolitis. N Engl J Med. 2011; 364(3):255-64. PMC: 3628622. DOI: 10.1056/NEJMra1005408. View

5.
De Plaen I . Inflammatory signaling in necrotizing enterocolitis. Clin Perinatol. 2013; 40(1):109-24. PMC: 3579498. DOI: 10.1016/j.clp.2012.12.008. View